IOI Pioneers Drug Therapies With Breakthrough Ketone Ester Technology
IOI Corporation Berhad (IOI), through our German subsidiary KetoLipix Therapeutics GmbH (KetoLipix), is leading pharmaceutical innovation by developing drug therapies for conditions with high unmet medical need, leveraging KetoLipix’s breakthrough ketone ester technology.
IOI Unveils Transformative Five-Year Strategic Roadmap for 2025 - 2029
IOI Corporation Berhad (IOI) has introduced a groundbreaking Five-Year Strategic Roadmap for 2025-2029 during an exclusive internal event, High-Tea With CEO, on 21 January 2025.
IOI Wins Most Caring & Best Company At HR Asia Awards 2024
IOI Corporation Berhad (IOI) proudly emerged as a dual award winner at the prestigious HR Asia Awards 2024.
IOI Leads Inaugural CEO Action Network’s Roundtable On Sustainable Waste Management And Circular Economy Practices
IOI Corporation Berhad (IOI) hosted the inaugural roundtable panel discussion with the CEO Action Network (CAN) for Workstream 1 (Waste and Circularity).
IOI Clinches Gold In Workplace Wellbeing Excellence At HREA 2024
IOI Corporation Berhad (IOI) was awarded a Gold Award for Excellence in Workplace Wellbeing during the 12th Human Resources Excellence Awards (HREA) 2024
IOI Foundation Awards RM323,000 In 2024 Scholarships To Empower 13 Recipients
IOI Foundation (formerly known as Yayasan Tan Sri Lee Shin Cheng) has awarded RM323,000 in scholarships to 13 recipients across diverse educational institutions
IOI Celebrates Third Consecutive Win At The Edge ESG Awards 2024
IOI Corporation Berhad (IOI) has once again won a Gold award in the plantation sector under the PLC category at the third The Edge Malaysia ESG Awards 2024
IOI Shines At NACGSA 2023/2024 With Double Win
IOI Corporation Berhad achieved a double victory at the MSWG’s recent National Corporate Governance & Sustainability Awards (NACGSA) 2024